Effective treatment for high cholesterol levels with comprehensive lipid management and cardiovascular protection.
Prevention of heart attack and stroke with comprehensive cardiovascular risk reduction and heart health protection.
Effective treatment of high triglycerides with excellent tolerability and proven cardiovascular benefits.
Rozmin contains Rosuvastatin, a powerful HMG-CoA reductase inhibitor (statin) medication designed for comprehensive cholesterol management and cardiovascular protection.
Rozmin works by inhibiting HMG-CoA reductase, the key enzyme responsible for cholesterol production in the liver, leading to:
Recommended starting dose for most patients with high cholesterol
Common maintenance dose for effective cholesterol control
Maximum dose for severe hypercholesterolemia cases
Comprehensive cholesterol and cardiovascular solutions tailored for different patient needs and lipid management requirements
Significant reduction in cholesterol levels and improved lipid profile management
Enhanced cardiovascular health protection and heart attack prevention
Excellent tolerability with minimal side effects in clinical studies
High patient satisfaction with improved quality of life and treatment outcomes